The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson’s Disease
Open accessAbstract
α-synuclein is a small protein abundantly expressed in the brain and mainly located in synaptic terminals. The conversion of α-synuclein into oligomers and fibrils is the hallmark of a range of neurodegenerative disorders including Parkinson's disease and dementia with Lewy bodies. α-synuclein is disordered in solution but can adopt an α-helical conformation upon binding to lipid membranes. This lipid-protein interaction plays an important role in its proposed biological function, i.e., synaptic plasticity, but can also entail the aggregation of the protein. Both the chemical properties of the lipids and the lipid-to-protein-ratio have been reported to modulate the aggregation propensity of α-synuclein. In this review, the influence of changes in the nature and levels of lipids on the aggregation propensity of α-synuclein in vivo and in vitro will be discussed within a common general framework. In particular, while biophysical measurements and kinetic analyses of the time courses of α-synuclein aggregation in the presence of different types of lipid vesicles allow a mechanistic dissection of the influence of the lipids on α-synuclein aggregation, biological studies of cellular and animal models of Parkinson's disease allow the determination of changes in lipid levels and properties associated with the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Prasanthi, J. R. P., Feist, G., Thomasson, S., Thompson, A. J., Schommer, E., & Ghribi, O. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05736.x · Cited by 100
RetractedMarwarha, G., Rhen, T., Schommer, T., & Ghribi, O. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07497.x · Cited by 90
RetractedSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Membrane lipids: where they are and how they behave
van Meer, G., Voelker, D. R., & Feigenson, G. W. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2330 · Cited by 7,157
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Molecular anatomy of a trafficking organelle
Takamori, S., Holt, M., Stenius, K., Lemke, E. A., Grønborg, M., Riedel, D., Urlaub, H., Schenck, S., Brügger, B., Ringler, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.030 · Cited by 2,373
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Burré, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M. R., & Südhof, T. C. (2010) · Science · doi:10.1126/science.1195227 · Cited by 1,812
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,641
Update of the LIPID MAPS comprehensive classification system for lipids
Fahy, E., Subramaniam, S., Murphy, R. C., Nishijima, M., Raetz, C. R. H., Shimizu, T., Spener, F., van Meer, G., Wakelam, M. J. O., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800095-jlr200 · Cited by 1,628
Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes
Davidson, W. S., Jonas, A., Clayton, D. F., & George, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9443 · Cited by 1,585
Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341
An Analytical Solution to the Kinetics of Breakable Filament Assembly
Knowles, T. P. J., Waudby, C. A., Devlin, G. L., Cohen, S. I. A., Aguzzi, A., Vendruscolo, M., Terentjev, E. M., Welland, M. E., & Dobson, C. M. (2009) · Science · doi:10.1126/science.1178250 · Cited by 1,139
Nemani, V. M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M. K., Chaudhry, F. A., Nicoll, R. A., & Edwards, R. H. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.023 · Cited by 1,056
Marsh, D. (2013) · CRC Press eBooks · doi:10.1201/b11712 · Cited by 828
Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins
Wilhelm, B. G., Mandad, S., Truckenbrodt, S., Kröhnert, K., Schäfer, C., Rammner, B., Koo, S. J., Claßen, G. A., Krauss, M., Haucke, V., et al. (2014) · Science · doi:10.1126/science.1252884 · Cited by 770
Lütjohann, D., Breuer, O., Ahlborg, G., Nennesmo, I., Sidén, A., Diczfalusy, U., & Björkhem, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9799 · Cited by 682
Buell, A. K., Galvagnion, C., Gaspar, R., Sparr, E., Vendruscolo, M., Knowles, T. P. J., Linse, S., & Dobson, C. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315346111 · Cited by 664
Self-citationLipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation
Galvagnion, C., Buell, A. K., Meisl, G., Michaels, T. C. T., Vendruscolo, M., Knowles, T. P. J., & Dobson, C. M. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1750 · Cited by 661
Self-citationPhenotype, diagnosis, and treatment of Gaucher's disease
Grabowski, G. A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61522-6 · Cited by 634
α-Synuclein Membrane Interactions and Lipid Specificity
Jo, E., McLaurin, J., Yip, C. M., St. George-Hyslop, P., & Fraser, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004345200 · Cited by 604
The Synaptic Function of α-Synuclein
Burré, J. (2015) · Journal of Parkinson's Disease · doi:10.3233/jpd-150642 · Cited by 573
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
Gegg, M. E., Burke, D., Heales, S. J. R., Cooper, J. M., Hardy, J., Wood, N. W., & Schapira, A. H. V. (2012) · Annals of Neurology · doi:10.1002/ana.23614 · Cited by 564
Sharon, R., Bar-Joseph, I., Frosch, M. P., Walsh, D. M., Hamilton, J. A., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00024-2 · Cited by 562
Schöndorf, D. C., Aureli, M., McAllister, F. E., Hindley, C. J., Mayer, F., Schmid, B., Sardi, S. P., Valsecchi, M., Hoffmann, S., Schwarz, L. K., et al. (2014) · Nature Communications · doi:10.1038/ncomms5028 · Cited by 543
A Broken α-Helix in Folded α-Synuclein
Chandra, S., Chen, X., Rizo, J., Jahn, R., & Südhof, T. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213128200 · Cited by 540
The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy
SPILLANTINI, M. G., & GOEDERT, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06900.x · Cited by 523
Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour
Fusco, G., De Simone, A., Gopinath, T., Vostrikov, V., Vendruscolo, M., Dobson, C. M., & Veglia, G. (2014) · Nature Communications · doi:10.1038/ncomms4827 · Cited by 480
Acceleration of α-Synuclein Aggregation by Exosomes
Grey, M., Dunning, C. J., Gaspar, R., Grey, C., Brundin, P., Sparr, E., & Linse, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.585703 · Cited by 377
Multiple Tight Phospholipid-Binding Modes of α-Synuclein Revealed by Solution NMR Spectroscopy
Bodner, C. R., Dobson, C. M., & Bax, A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.05.066 · Cited by 376
Bosco, D. A., Fowler, D. M., Zhang, Q., Nieva, J., Powers, E. T., Wentworth, P., Lerner, R. A., & Kelly, J. W. (2006) · Nature Chemical Biology · doi:10.1038/nchembio782 · Cited by 349
Oxysterols: From cholesterol metabolites to key mediators
Mutemberezi, V., Guillemot-Legris, O., & Muccioli, G. G. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.09.002 · Cited by 335
Osellame, L. D., Rahim, A. A., Hargreaves, I. P., Gegg, M. E., Richard-Londt, A., Brandner, S., Waddington, S. N., Schapira, A. H. V., & Duchen, M. R. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.014 · Cited by 334
Zhu, M., Li, J., & Fink, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305326200 · Cited by 323
Membrane Curvature Induction and Tubulation Are Common Features of Synucleins and Apolipoproteins
Varkey, J., Isas, J. M., Mizuno, N., Jensen, M. B., Bhatia, V. K., Jao, C. C., Petrlova, J., Voss, J. C., Stamou, D. G., Steven, A. C., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139576 · Cited by 319
Sardi, S. P., Clarke, J., Kinnecom, C., Tamsett, T. J., Li, L., Stanek, L. M., Passini, M. A., Grabowski, G. A., Schlossmacher, M. G., Sidman, R. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108197108 · Cited by 319
Lipid Binding Inhibits α-Synuclein Fibril Formation
Zhu, M., & Fink, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210136200 · Cited by 314
Galvagnion, C., Brown, J. W. P., Ouberai, M. M., Flagmeier, P., Vendruscolo, M., Buell, A. K., Sparr, E., & Dobson, C. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601899113 · Cited by 308
Self-citationCullen, V., Sardi, S. P., Ng, J., Xu, Y., Sun, Y., Tomlinson, J. J., Kolodziej, P., Kahn, I., Saftig, P., Woulfe, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22400 · Cited by 303
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity
Perni, M., Galvagnion, C., Maltsev, A., Meisl, G., Müller, M. B. D., Challa, P. K., Kirkegaard, J. B., Flagmeier, P., Cohen, S. I. A., Cascella, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610586114 · Cited by 298
Self-citationExposure to Long Chain Polyunsaturated Fatty Acids Triggers Rapid Multimerization of Synucleins
Perrin, R. J., Woods, W. S., Clayton, D. F., & George, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105022200 · Cited by 279
The Presence of an Air–Water Interface Affects Formation and Elongation of α-Synuclein Fibrils
Campioni, S., Carret, G., Jordens, S., Nicoud, L., Mezzenga, R., & Riek, R. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412105t · Cited by 270
GM1 Specifically Interacts with α-Synuclein and Inhibits Fibrillation
Martinez, Z., Zhu, M., Han, S., & Fink, A. L. (2007) · Biochemistry · doi:10.1021/bi061749a · Cited by 260
Dietary fatty acids and the risk of Parkinson disease: The Rotterdam Study
de Lau, L. M. L., Bornebroek, M., Witteman, J. C. M., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2005) · Neurology · doi:10.1212/01.wnl.0000166038.67153.9f · Cited by 259
Quantification of α-Synuclein Binding to Lipid Vesicles Using Fluorescence Correlation Spectroscopy
Rhoades, E., Ramlall, T. F., Webb, W. W., & Eliezer, D. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.079251 · Cited by 257
Gaspar, R., Meisl, G., Buell, A. K., Young, L., Kaminski, C. F., Knowles, T. P. J., Sparr, E., & Linse, S. (2017) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583516000172 · Cited by 249
Magalhaes, J., Gegg, M. E., Migdalska-Richards, A., Doherty, M. K., Whitfield, P. D., & Schapira, A. H. V. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw185 · Cited by 234
Jo, E., Fuller, N., Rand, R. P., St George-Hyslop, P., & Fraser, P. E. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5269 · Cited by 233
Alpha-synuclein, lipids and Parkinson’s disease
Ruipérez, V., Darios, F., & Davletov, B. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.05.004 · Cited by 231
Aflaki, E., Borger, D. K., Moaven, N., Stubblefield, B. K., Rogers, S. A., Patnaik, S., Schoenen, F. J., Westbroek, W., Zheng, W., Sullivan, P., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0636-16.2016 · Cited by 227
Chemical kinetics for drug discovery to combat protein aggregation diseases
Arosio, P., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.12.005 · Cited by 219
Ouberai, M. M., Wang, J., Swann, M. J., Galvagnion, C., Guilliams, T., Dobson, C. M., & Welland, M. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478297 · Cited by 208
Self-citationTotal cholesterol and the risk of Parkinson disease
Hu, G., Antikainen, R., Jousilahti, P., Kivipelto, M., & Tuomilehto, J. (2008) · Neurology · doi:10.1212/01.wnl.0000312511.62699.a8 · Cited by 206
Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice
Migdalska‐Richards, A., Daly, L., Bezard, E., & Schapira, A. H. V. (2016) · Annals of Neurology · doi:10.1002/ana.24790 · Cited by 204
Definition of a Molecular Pathway Mediating α-Synuclein Neurotoxicity
Burré, J., Sharma, M., & Südhof, T. C. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4650-14.2015 · Cited by 202
Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage
Cleeter, M. W. J., Chau, K.-Y., Gluck, C., Mehta, A., Hughes, D. A., Duchen, M., Wood, N. W., Hardy, J., Mark Cooper, J., & Schapira, A. H. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.10.010 · Cited by 201
Monomeric Synucleins Generate Membrane Curvature
Westphal, C. H., & Chandra, S. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.418871 · Cited by 199
Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex
Cheng, D., Jenner, A. M., Shui, G., Cheong, W. F., Mitchell, T. W., Nealon, J. R., Kim, W. S., McCann, H., Wenk, M. R., Halliday, G. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017299 · Cited by 189
Sharon, R., Bar-Joseph, I., Mirick, G. E., Serhan, C. N., & Selkoe, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309127200 · Cited by 187
Oxysterols, cholesterol homeostasis, and Alzheimer disease
Vaya, J., & Schipper, H. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04689.x · Cited by 183
Manning-Boğ, A. B., Schüle, B., & Langston, J. W. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.06.009 · Cited by 176
Viable Mouse Models of Acid β-Glucosidase Deficiency
Xu, Y.-H., Quinn, B., Witte, D., & Grabowski, G. A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63566-3 · Cited by 170
Bartels, T., Kim, N. C., Luth, E. S., & Selkoe, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103727 · Cited by 164
Membrane Interaction of α-Synuclein in Different Aggregation States
Grey, M., Linse, S. S., Nilsson, H., Brundin, P., & Sparr, E. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11067 · Cited by 159
Lipid sorting and multivesicular endosome biogenesis
Bissig, C., & Gruenberg, J. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016816 · Cited by 151
Xu, Y. H., Sun, Y., Ran, H., Quinn, B., Witte, D. P., & Grabowski, G. A. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.12.014 · Cited by 139
Glucosylceramide modulates membrane traffic along the endocytic pathway
Sillence, D. J., Puri, V., Marks, D. L., Butters, T. D., Dwek, R. A., Pagano, R. E., & Platt, F. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200232-jlr200 · Cited by 124
Membrane Lipid Co-Aggregation with α-Synuclein Fibrils
Hellstrand, E., Nowacka, A., Topgaard, D., Linse, S. S., & Sparr, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077235 · Cited by 123
α‐Synuclein sequesters arachidonic acid to modulate SNARE‐mediated exocytosis
Darios, F. D., Ruipérez, V., López‐Font, I., Villanueva, J., Gutiérrez, L. M., & Davletov, B. A. (2010) · EMBO Reports · doi:10.1038/embor.2010.66 · Cited by 117
Glucocerebrosidase mutations and the pathogenesis of Parkinson disease
Beavan, M. S., & Schapira, A. H. V. (2013) · Annals of Medicine · doi:10.3109/07853890.2013.849003 · Cited by 115
Membrane Remodeling by α-Synuclein and Effects on Amyloid Formation
Jiang, Z., de Messieres, M., & Lee, J. C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405993r · Cited by 112
Fusco, G., De Simone, A., Arosio, P., Vendruscolo, M., Veglia, G., & Dobson, C. M. (2016) · Scientific Reports · doi:10.1038/srep27125 · Cited by 110
Polyunsaturated Fatty Acids Induce α-Synuclein-Related Pathogenic Changes in Neuronal Cells
Assayag, K., Yakunin, E., Loeb, V., Selkoe, D. J., & Sharon, R. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070373 · Cited by 109
Franceschi, G. D., Frare, E., Pivato, M., Relini, A., Penco, A., Greggio, E., Bubacco, L., Fontana, A., & de Laureto, P. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.202937 · Cited by 109
Elevated GM3 plasma concentration in idiopathic Parkinson’s disease: A lipidomic analysis
Chan, R., Perotte, A., Zhou, B., Liong, C., Shorr, E., Marder, K. S., Kang, U. J., Waters, C., Levy, O. A., Xu, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172348 · Cited by 106
Adsorption of α-Synuclein to Supported Lipid Bilayers: Positioning and Role of Electrostatics
Hellstrand, E., Grey, M., Ainalem, M.-L., Ankner, J. F., Forsyth, V. T., Fragneto, G., Haertlein, M., Dauvergne, M.-T., Nilsson, H., Brundin, P., et al. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400066t · Cited by 105
Suzuki, M., Fujikake, N., Takeuchi, T., Kohyama‐Koganeya, A., Nakajima, K., Hirabayashi, Y., Wada, K., & Nagai, Y. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv372 · Cited by 102
Braun, A. R., Lacy, M. M., Ducas, V. C., Rhoades, E. R., & Sachs, J. N. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5016958 · Cited by 101
Dietary fats, cholesterol and iron as risk factors for Parkinson's disease
Powers, K. M., Smith-Weller, T., Franklin, G. M., Longstreth, W. T., Swanson, P. D., & Checkoway, H. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.03.002 · Cited by 100 · cited 1×
“The relationship between high cholesterol levels and PD is, however, controversial as elevated serum levels of cholesterol were related to either an increase [96, 97] or a decrease of the risk of PD [98] or not to be associated with PD [99, 100].”
BackgroundBroersen, K., van den Brink, D. M., Fraser, G. M., Goedert, M., & Davletov, B. A. (2006) · Biochemistry · doi:10.1021/bi061743l · Cited by 98
Depth of α-Synuclein in a Bilayer Determined by Fluorescence, Neutron Reflectometry, and Computation
Pfefferkorn, C. M., Heinrich, F., Sodt, A. J., Maltsev, A. S., Pastor, R. W., & Lee, J. C. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2011.12.051 · Cited by 97
Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease–Parkinson's disease overlap?
Marwarha, G., & Ghribi, O. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.013 · Cited by 89
Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP
Huang, X., Auinger, P., Eberly, S. W., Oakes, D., Schwarzschild, M. A., Ascherio, A., Mailman, R. B., Chen, H., & for the Parkinson Study Group DATATOP Investigators (2011) · PLoS ONE · doi:10.1371/journal.pone.0022854 · Cited by 82
Brown, J. W., Buell, A. K., Michaels, T. C. T., Meisl, G., Carozza, J. A., Flagmeier, P., Vendruscolo, M., Knowles, T. P. J., Dobson, C. M., & Galvagnion, C. (2016) · Scientific Reports · doi:10.1038/srep36010 · Cited by 82
Self-citationα-Synuclein Oligomers with Broken Helical Conformation Form Lipoprotein Nanoparticles
Varkey, J., Mizuno, N., Hegde, B. G., Cheng, N., Steven, A. C., & Langen, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476697 · Cited by 75
Yang, S., Beavan, M. S., Chau, K., Taanman, J., & Schapira, A. H. V. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.01.011 · Cited by 73
Sun, Y., Quinn, B., Witte, D. P., & Grabowski, G. A. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500202-jlr200 · Cited by 72
Pandey, A. P., Haque, F., Rochet, J., & Hovis, J. S. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.10.011 · Cited by 65
Pirc, K., & Ulrih, N. P. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.06.021 · Cited by 64
Arachidonic acid mediates the formation of abundant alpha-helical multimers of alpha-synuclein
Iljina, M., Tosatto, L., Choi, M. L., Sang, J. C., Ye, Y., Hughes, C. D., Bryant, C. E., Gandhi, S., & Klenerman, D. (2016) · Scientific Reports · doi:10.1038/srep33928 · Cited by 63
Karube, H., Sakamoto, M., Arawaka, S., Hara, S., Sato, H., Ren, C.-H., Goto, S., Koyama, S., Wada, M., Kawanami, T., et al. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.001 · Cited by 62
Preparation and Characterization of Stable α-Synuclein Lipoprotein Particles
Eichmann, C., Campioni, S., Kowal, J., Maslennikov, I., Gerez, J., Liu, X., Verasdonck, J., Nespovitaya, N., Choe, S., Meier, B. H., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.707968 · Cited by 55
α-Synuclein Oligomers Induced by Docosahexaenoic Acid Affect Membrane Integrity
Fecchio, C., Franceschi, G. D., Relini, A., Greggio, E., Serra, M. D., Bubacco, L., & de Laureto, P. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082732 · Cited by 53
Garten, M., Prévost, C., Cadart, C., Gautier, R., Bousset, L., Melki, R., Bassereau, P. M., & Vanni, S. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp00244c · Cited by 53
Biophysics of α-synuclein induced membrane remodelling
Shi, Z., Sachs, J. N., Rhoades, E. R., & Baumgart, T. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c4cp05883f · Cited by 52
The late endosome/lysosome-anchored p18-mTORC1 pathway controls terminal maturation of lysosomes
Takahashi, Y., Nada, S., Mori, S., Soma‐Nagae, T., Oneyama, C., & Okada, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.082 · Cited by 51
Salvioli, R., Tatti, M., Scarpa, S., Moavero, S. M., Ciaffoni, F., Felicetti, F., Kaneski, C. R., Brady, R. O., & Vaccaro, A. M. (2005) · Biochemical Journal · doi:10.1042/bj20050325 · Cited by 49
Gene–gene interaction between heme oxygenase-1 and liver X receptor-β and Alzheimer's disease risk
Infante, J., Rodríguez‐Rodríguez, E., Mateo, I., Llorca, J., Vázquez‐Higuera, J. L., Berciano, J., & Combarros, O. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.025 · Cited by 48
α-Synuclein-Induced Tubule Formation in Lipid Bilayers
Pandey, A. P., Haque, F., Rochet, J., & Hovis, J. S. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp1121917 · Cited by 44
Total Cholesterol and the Risk of Parkinson's Disease: A Review for Some New Findings
Hu, G. (2009) · Parkinson s Disease · doi:10.4061/2010/836962 · Cited by 39
Haque, F., Pandey, A. P., Cambrea, L. R., Rochet, J., & Hovis, J. S. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp1006704 · Cited by 37
Franceschi, G. D., Fecchio, C., Sharon, R., Schapira, A. H. V., Proukakis, C., Bellotti, V., & de Laureto, P. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.765149 · Cited by 37
Intracellular cholesterol modifies the ERAD of glucocerebrosidase in Gaucher disease patients☆
Ron, I., & Horowitz, M. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.10.132 · Cited by 34
Regulation of α-synuclein expression by liver X receptor ligands in vitro
Cheng, D., Kim, W. S., & Garner, B. (2008) · Neuroreport · doi:10.1097/wnr.0b013e32831578b2 · Cited by 32
Pantusa, M., Vad, B. S., Lillelund, O., Kjær, L., Otzen, D. E., & Bartucci, R. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.05.003 · Cited by 20
Cited by
Secondary nucleation in amyloid formation
Törnquist, M., Michaels, T. C. T., Sanagavarapu, K., Yang, X., Meisl, G., Cohen, S. I. A., Knowles, T. P. J., & Linse, S. (2018) · Chemical Communications · doi:10.1039/c8cc02204f · Cited by 467
Quinville, B. M., Deschenes, N. M., Ryckman, A. E., & Walia, J. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115793 · Cited by 343
Fanning, S., Haque, A., Imberdis, T., Baru, V., Barrasa, M. I., Nuber, S., Termine, D., Ramalingam, N., Ho, G. P. H., Noble, T., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.11.028 · Cited by 285
Initiation and propagation of α-synuclein aggregation in the nervous system
Hijaz, B. A., & Volpicelli-Daley, L. A. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00368-6 · Cited by 262
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
Alecu, I., & Bennett, S. A. L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00328 · Cited by 258
Metadata
- Authors
- Galvagnion, C.
- Venue
- Journal of Parkinson's Disease
- Publisher
- SAGE Publications
- Published
- 2017-08-08
- Volume
- 7
- Issue
- 3
- Pages
- 433-450
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- OpenAlex
- W2727376740
- Cited by
- 258
- References
- 106
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.